Squarepoint
ACER

Squarepoint’s Acer Therapeutics Inc ACER Stock Holding History

Squarepoint’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,014
Closed -$233K – 3848
2021
Q1 		$233K Buy
+75,014
New +$255K ﹤0.01% 2602
2019
Q3 		– Sell
-10,993
Closed -$43K – 2760
2019
Q2 		$43K Buy
+10,993
New +$210K ﹤0.01% 2287

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Squarepoint's ACER Position: Q2 2021 in Review

Squarepoint sold out of Acer Therapeutics Inc (ACER) in Q2 2021, closing a stake of 75,014 shares — an estimated $233K sold.

Squarepoint first reported a position in ACER in Q2 2019 and held it in 2 quarters. The position peaked at $233K in Q1 2021. 30 funds tracked by Wall St. Rank hold ACER as of Q2 2021.

  • Squarepoint reported no remaining Acer Therapeutics Inc position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 75,014 Acer Therapeutics Inc shares in Q2 2021, an estimated $233K.
  • Squarepoint first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 2 quarters.
  • Squarepoint's Acer Therapeutics Inc position peaked at $233K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.